Jianjun Han
Peking Union Medical College
10 Papers
29 Citations
Jianjun Han is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis.
TL;DR: R-LAR was shown to be associated with a shorter hospital stay, lower conversion rate, lower rate of circumferential margin involvement, and lower overall complication rate compared with conventional laparoscopic low anterior resection.
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hailiang Li,Min Huang,Wei Zhu Yang,Guo-Wen Yin,Bin-Yan Zhong,Jun-Hui Sun,Zhi-Cheng Jin,Jian-Jian Chen,Nai-Jian Ge,Wen-Bin Ding,Wenhui Li,Jin Hua Huang,Wei-Ping Mu,Shanzhi Gu,Jianping Li,Huijun Zhao,Shu-Wei Wen,Yan-ming Lei,Yuejiao Song,Chunwang Yuan,Weidong Wang,Ming Huang,Wei Zhao,Jianbing Wu,Song Wang,Xu Zhu,Jianjun Han,Weixin Ren,Zaiming Lu,Wenfeng Xing,Yong Fan,Hai-Lan Lin,Zishu Zhang,Guo-Hui Xu,Wenjing Hu,Qiang Tu,Hongying Su,Chuansheng Zheng,Yong Chen,Xuejin Zhao,Zhu-Ting Fang,Qi Wang,Jinxian Zhao,Ai-Bing Xu,Jian Xu,Qing-Hua Wu,Huan-zhang Niu,Jian Zhong Wang,Feng Dai,Duiping Feng,Qingyun Li,Rongshu Shi,Jia-Rui Li,Guang Yang,Hai-Bin Shi,Jian-Song Ji,Yu'e Liu,Z W Cai,Po Yang,Yang Zhao,Xiaoli Zhu,Ligong Lu,Gao-Jun Teng +62 more
TL;DR: Wang et al. as discussed by the authors investigated the therapeutic efficacy and safety of transarterial chemoembolization (TACE) combined with PD-(L)1 inhibitors and MTT in real-world situations.
Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer
TL;DR: The results indicate that miR-181A expression is associated with CRC patients with late liver metastases through PTEN/AKT signaling.
Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes
TL;DR: The combination of transarterial chemoembolization and metformin may be associated with better OS and PFS in HCC patients with T2DM.
[Silencing HMGB1 expression by lentivirus-mediated small interfering RNA (siRNA) inhibits the proliferation and invasion of colorectal cancer LoVo cells in vitro and in vivo].
TL;DR: Lentivirus-mediated HMGBl-siRNA can effectively inhibit the HMGB1 expression in colorectal cancer LoVo cells both in vitro and in vivo.
7